Reexamining Risks of Prenatal Cannabis Use-Mounting Evidence and a Call to Action

JAMA Netw Open. 2022 Jan 4;5(1):e2145666. doi: 10.1001/jamanetworkopen.2021.45666.

Authors

Kara R Skelton¹, Sara E Benjamin-Neelon²

Affiliations

¹ Department of Health Sciences, College of Health Professions, Towson University, Towson, Maryland.
² Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

PMID: 35084486
DOI: 10.1001/jamanetworkopen.2021.45666

No abstract available

Publication types

Comment

MeSH terms

Analgesics
Cannabinoid Receptor Agonists
Cannabis* / adverse effects
Female
Hallucinogens*
Humans
Pregnancy

Substances

Analgesics
Cannabinoid Receptor Agonists
Hallucinogens